Patrick LACARIN, CHU Clermont-Ferrand [clinicaltrials_resource:b35341ea76855f886e3c93e1fdec9f21]
Ceftazidime Pharmacokinetic in Cerebrospinal Fluid Between Continuous and Intermittent Administration [clinicaltrials:NCT00752882]Low-energy Laser Therapy for Prevention of Oral Mucositis in Children [clinicaltrials:NCT01007617]Recruitment Maneuver After Intubation [clinicaltrials:NCT01014299]Acute Exercise and Energy Balance Regulation: Effect of Intensity [clinicaltrials:NCT01036360]Concomitant Tracheostomy and Lung Resection [clinicaltrials:NCT01053624]Substrate Utilization and Hormonal Status in Women [clinicaltrials:NCT01095614]Glucose Tolerance in Patients With an Idiopathic Parkinson's Disease [clinicaltrials:NCT01114321]Impact on the Proteolysis of Obesity in Dialysis [clinicaltrials:NCT01114789]Paracetamol and Glutathion [clinicaltrials:NCT01116596]Impact of Oral Magnesium on Neuropathic Pain [clinicaltrials:NCT01121653]Paracetamol Metabolism in Post Operative Conditions [clinicaltrials:NCT01152502]Haplo-identical Hematopoietic Stem Cell Transplantation Following Reduced-intensity Conditioning in Children With Neuroblastoma [clinicaltrials:NCT01156350]Pharmacokinetic of Sevoflurane During a 48h Sedation in Intensive Care Unit With AnaConDa® [clinicaltrials:NCT01196754]Facial Expression Recognition and Mirror Neurons in Parkinson's Disease [clinicaltrials:NCT01315405]Sleep Apnea Syndrome and Vitamin D [clinicaltrials:NCT01323218]Effects of 3 Months of Supervised Exercise Training [clinicaltrials:NCT01349166]Rest/Stress Quantification Of Left Ventricular Dyssynchrony By 3D Gated Blood Pool D-SPECT [clinicaltrials:NCT01390532]clinicaltrials:NCT01392872
responsible party [clinicaltrials_vocabulary:responsible-party]
Patrick LACARIN, CHU Clermont-Ferrand [clinicaltrials_resource:b35341ea76855f886e3c93e1fdec9f21]
Bio2RDF identifier
b35341ea76855f886e3c93e1fdec9f21
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:b35341ea76855f886e3c93e1fdec9f21
name title [clinicaltrials_vocabulary:name-title]
Patrick LACARIN
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:b35341ea76855f886e3c93e1fdec9f21
title
Patrick LACARIN, CHU Clermont-Ferrand
@en
type
label
Patrick LACARIN, CHU Clermont- ...... 341ea76855f886e3c93e1fdec9f21]
@en